Cefteram Pivoxil is an oral third-generation cephalosporin prodrug used primarily in Japan and other Asian markets for upper respiratory and urinary tract infections. Simson Pharma's Cefteram Pivoxil reference standard and impurities support compendial testing for this regional oral beta-lactam.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Cefteram Pivoxil Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.